Annika Kasprzak

Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Comparison of time to therapy initiation, therapeutic strategies and survival in patients with MDS IB1, IB2 and AML-MR using data of the duesseldorf registries.

Comparison of time to therapy initiation, therapeutic strategies and survival in patients with MDS IB1, IB2 and AML-MR using data of the duesseldorf registries.

Journal: Annals of hematology

Published: May 15, 2026

Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromes.

Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromes.

Journal: Annals of hematology

Published: February 06, 2026

Impact of early tacrolimus exposure on outcomes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.

Impact of early tacrolimus exposure on outcomes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.

Journal: Annals of hematology

Published: January 26, 2026

Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.

Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.

Journal: Annals of hematology

Published: November 10, 2025

Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice.

Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice.

Journal: Annals of hematology

Published: June 30, 2025

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis.

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis.

Journal: Annals of hematology

Published: May 15, 2025

Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS).

Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS).

Journal: Annals of hematology

Published: April 02, 2025

Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors-A Single Center Experience in 152 Patients.

Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors-A Single Center Experience in 152 Patients.

Journal: EJHaem

Published: January 29, 2025

Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience.

Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience.

Journal: Annals of hematology

Published: September 24, 2024

MDS patient registries - achievements and challenges.

MDS patient registries - achievements and challenges.

Journal: Annals of hematology

Published: May 30, 2024

Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry.

Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry.

Journal: Cancers

Published: January 29, 2024

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.

Journal: Cancers

Published: November 24, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026